Successful Rechallenge With Ceritinib After Leukocytoclastic Vasculitis During Ceritinib Treatment for Non-Small Cell Lung Cancer Harboring the EML4-ALK Fusion Protein
Oncotarget - United States
doi 10.18632/oncotarget.24765
Full Text
Open PDFAbstract
Available in full text
Categories
Date
March 16, 2018
Authors
Publisher
Impact Journals, LLC